Organisation paid for research Program year 2021 Source: CMS Open Payments

Futura Research Org

Neither a doctor nor a teaching hospital

Research payments

$226,206

81 payments

Through program year 2021, Futura Research Org is reported as receiving $226,206 in research payments, across 81 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2021	Research	$5,988	8
2020	Research	$38,585	19
2019	Research	$181,633	54

Breakdown

Who paid Research payments · program years 2019–2021

AbbVie, Inc. $189,051 76 payments
Mitsubishi Tanabe Pharma Development America, Inc. $33,660 3 payments
Myovant Sciences Inc. $3,495 2 payments

Studies the money was for Research payments · program years 2019–2021

M16-283 $106,974 40 payments
M14-702 $56,155 23 payments
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women $24,215 1 payment
An Open-label, Long Term Extension Study of MT-8554 in Postmenopausal Women Experiencing Moderate to Severe Vasomotor Symptoms Who Completed Study MT-8554-A01 $9,445 2 payments
M12-816 $8,930 5 payments
M18-969 $8,000 1 payment
F16-974 $6,500 1 payment
An International Phase 3 Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of Relugolix With Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids $3,495 2 payments
A Phase 3b Study to Evaluate the Long-Term Safety of Elagolix in Combination with Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated with Uterine Fibroids in Premenopausal Women $2,493 6 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.